Genomic medicine is rapidly changing the healthcare paradigm for multiple conditions, including cancer and rare diseases. With governments around the world increasingly investing in genomics research and implementation into clinical practice, and with the health economics evidence base on genomic medicine expanding, it is important to reflect on the role of health economics to change …

Prioritising genomic medicine: reflections on the role of health economics for changing policy and clinical practice Read More »